InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,707.85
(
1.41%
)
Post# of 11530
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

SchragerTrader23

Send PM Follow Ignore
Followers 229
Posts 24645
Boards Moderated 0
Alias Born 09/26/2011

SchragerTrader23

Re: SchragerTrader23 post# 9639

Thursday, 08/14/2014 12:03:09 PM

Thursday, August 14, 2014 12:03:09 PM

Post# of 11530
CIHN Regenerative Bioscience’s physicians treat patients with ex-vivo generated autologous Angiogenic Cell Precursors (ACP’s), which are derived from the patient’s own bone marrow aspirate taken from the pelvic bone using modern techniques which allow for patient comfort. These adult stem cells are capable of promoting the formation of new vascularization and viable tissue. The mononuclear cells are isolated and concentrated at the same location as the treatment.

Join The Matrix!

http://investorshub.advfn.com/PSIONIC-MATRIX%ce%a8-2059/

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up